dihydroxyphenylalanine has been researched along with Polycystic Ovary Syndrome in 1 studies
Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.
Polycystic Ovary Syndrome: A complex disorder characterized by infertility, HIRSUTISM; OBESITY; and various menstrual disturbances such as OLIGOMENORRHEA; AMENORRHEA; ANOVULATION. Polycystic ovary syndrome is usually associated with bilateral enlarged ovaries studded with atretic follicles, not with cysts. The term, polycystic ovary, is misleading.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Garcia-Rudaz, C | 1 |
| Armando, I | 1 |
| Levin, G | 1 |
| Escobar, ME | 1 |
| Barontini, M | 1 |
1 other study available for dihydroxyphenylalanine and Polycystic Ovary Syndrome
| Article | Year |
|---|---|
Peripheral catecholamine alterations in adolescents with polycystic ovary syndrome.
Topics: Adolescent; Adult; Analysis of Variance; Androgens; Case-Control Studies; Catecholamines; Dihydroxyp | 1998 |